Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L8EO
|
||||
Former ID |
DIB010079
|
||||
Drug Name |
Anti-TLR3 mabs
|
||||
Synonyms |
Anti-TLR3 mAbs (autoimmune and inflammatory disorders)
|
||||
Drug Type |
Monoclonal antibody
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Investigative | [543473] | ||
Company |
Innate Pharma SA
|
||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 3 | Target Info | Modulator | [543473] | |
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
Pathway Interaction Database | Endogenous TLR signaling | ||||
Reactome | Ligand-dependent caspase activation | ||||
MyD88-independent TLR3/TLR4 cascade | |||||
Trafficking and processing of endosomal TLR | |||||
RIP-mediated NFkB activation via ZBP1 | |||||
TRIF-mediated programmed cell death | |||||
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |||||
IKK complex recruitment mediated by RIP1 | |||||
TRAF6 mediated induction of TAK1 complex | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.